![]() Bioxytran Bioxytran (formerly known as U.S. Rare Earth Minerals) is a clinical stage pharmaceutical company developing platform technologies. | ![]() Proteome Sciences Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications | ![]() Cellis Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology. | |
Founding Date | Founding Date 2008 | Founding Date N/A | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Newton, US HQ Newton, US | Locations Addlestone, GB HQ Frankfurt Am Main, DE Cobham, GB | Locations Zürich, CH HQ Warsaw, PL |
Employees | Employees 3 | Employees 363% increase | Employees 23 |
Valuation ($) | Valuation ($) 8.1 m | Valuation ($) 10.5 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($2.1m) (FY, 2025) | Net income (£3.1m) (FY, 2025) | Net income N/A |

Reaching New Heights in Biomarker Solutions-Protein and peptide biomarker solutions for pharmaceutical and diagnostics applications
View company
Cellis is a company that develops therapeutic and diagnostic solutions with a focus on nanotechnology, oncology, and molecular biology.
View company